Home Judo Bio

Judo Bio

In operation
-
Oligonucleotide Therapy Developer
Basic
Enterprise Profile

Basic Information

Judo Bio is a developer of oligonucleotide therapies aimed at providing genetic medicines. The company helps pair gene-silencing nucleic acids with targeting molecules for specific types of kidney cells, enabling healthcare professionals to treat systemic and kidney diseases.
Judo Bio Inc.
Cambridge,Massachusetts,United States of America
unclear
January 01, 2021
--
--

Enterprise Profile

Industrial Sector
Compound Discovery Compound Design New Drug Development
Technology
Targeted Technology
Concept
Therapeutic Products
Application Scenarios
Innovative Drugs